Suppr超能文献

组蛋白/蛋白质去乙酰化酶控制 Foxp3 的表达和 T 调节细胞的热休克反应。

Histone/protein deacetylases control Foxp3 expression and the heat shock response of T-regulatory cells.

机构信息

Division of Nephrology, Department of Pediatrics, The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, USA.

出版信息

Curr Opin Immunol. 2011 Oct;23(5):670-8. doi: 10.1016/j.coi.2011.07.002. Epub 2011 Jul 26.

Abstract

Lysine ɛ-acetylation is a post-translational modification that alters the biochemical properties of many proteins. The reaction is catalyzed by histone/protein acetyltransferases (HATs), and is reversed by histone/protein deacetylases (HDACs). As a result, HATs and HDACs constitute an important, though little recognized, set of proteins that control the functions of T-regulatory (Treg) cells. Targeting certain HDACs, especially HDAC6, HDAC9, and Sirtuin-1 (Sirt1), can augment Treg suppressive potency by several distinct and potentially additive mechanisms. These involve promoting Forkhead box p3 (Foxp3) gene expression and preserving Foxp3 lysine ɛ-acetylation, which infers resistance to ubiquitination and proteasomal degradation, and increases DNA binding. Moreover, depleting certain HDAC can enhance the heat shock response, which increases the tenacity of Treg to survive under stress, and helps preserve a suppressive phenotype. As a result, HDAC inhibitor therapy can be used to enhance Treg functions in vivo and have beneficial effects on allograft survival and autoimmune diseases.

摘要

赖氨酸ɛ-乙酰化是一种翻译后修饰,可改变许多蛋白质的生化特性。该反应由组蛋白/蛋白乙酰转移酶(HATs)催化,并由组蛋白/蛋白去乙酰化酶(HDACs)逆转。因此,HATs 和 HDACs 构成了一组重要的、但尚未被充分认识的蛋白质,它们控制 T 调节(Treg)细胞的功能。靶向某些 HDAC,特别是 HDAC6、HDAC9 和 Sirtuin-1(Sirt1),可以通过几种不同的、潜在的累加机制增强 Treg 的抑制效力。这些机制涉及促进叉头框 p3(Foxp3)基因表达和维持 Foxp3 赖氨酸ɛ-乙酰化,这意味着对泛素化和蛋白酶体降解具有抗性,并增加 DNA 结合。此外,消耗某些 HDAC 可以增强热休克反应,从而提高 Treg 在应激下的生存能力,并有助于维持抑制表型。因此,HDAC 抑制剂治疗可用于增强体内 Treg 功能,并对同种异体移植物存活和自身免疫性疾病产生有益影响。

相似文献

9
Targeting FOXP3 complex ensemble in drug discovery.靶向 FOXP3 复合物共组装的药物研发。
Adv Protein Chem Struct Biol. 2020;121:143-168. doi: 10.1016/bs.apcsb.2019.11.010. Epub 2020 Jan 7.

引用本文的文献

3
Role of histone deacetylase inhibitors in non-neoplastic diseases.组蛋白去乙酰化酶抑制剂在非肿瘤性疾病中的作用。
Heliyon. 2024 Jul 2;10(13):e33997. doi: 10.1016/j.heliyon.2024.e33997. eCollection 2024 Jul 15.
7
SIRT1: A promising therapeutic target for chronic pain.SIRT1:慢性疼痛有希望的治疗靶点。
CNS Neurosci Ther. 2022 Jun;28(6):818-828. doi: 10.1111/cns.13838. Epub 2022 Apr 9.
8
Valproic Acid Inhibits Glioma and Its Mechanisms.丙戊酸抑制神经胶质瘤及其机制。
J Healthc Eng. 2022 Feb 10;2022:4985781. doi: 10.1155/2022/4985781. eCollection 2022.

本文引用的文献

2
Moving to tolerance: clinical application of T regulatory cells.向耐受转化:调节性 T 细胞的临床应用。
Semin Immunol. 2011 Aug;23(4):304-13. doi: 10.1016/j.smim.2011.04.001. Epub 2011 May 28.
5
Autoimmunity associated with immunotherapy of cancer.癌症免疫治疗相关的自身免疫。
Blood. 2011 Jul 21;118(3):499-509. doi: 10.1182/blood-2011-01-325266. Epub 2011 Apr 29.
6
Regulatory T cells and Foxp3.调节性 T 细胞和 Foxp3。
Immunol Rev. 2011 May;241(1):260-8. doi: 10.1111/j.1600-065X.2011.01018.x.
10

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验